Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne Thoury is active.

Publication


Featured researches published by Anne Thoury.


Annals of Surgical Oncology | 2005

Results of Hysterectomy in Patients With Bulky Residual Disease at the End of Chemoradiotherapy for Stage IB2/II Cervical Carcinoma

Elie Azria; Philippe Morice; Christine Haie-Meder; Anne Thoury; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne

BackgroundWe assessed the clinical outcome after hysterectomy in patients with bulky residual disease after chemoradiotherapy for stage IB2/II cervical carcinoma.MethodsSubjects were 10 patients who had bulky (>2 cm) residual disease in the cervix after external radiotherapy (45 Gy) combined with concomitant chemotherapy (cisplatin 40 mg/m2/week) and uterovaginal brachytherapy (15 Gy).ResultsExtrafascial hysterectomy was performed in three patients, type II radical hysterectomy was performed in six patients, and pelvic exenteration was performed in one patient. Pelvic lymphadenectomy was performed in eight patients, and para-aortic lymphadenectomy was performed in eight. Five patients had nodal involvement (pelvic nodes in four and para-aortic nodes in four), and six had lymphovascular space involvement. Surgical margins were free in nine patients. Seven patients developed grade 2 (n = 3) and/or grade 3 (n = 4) complications. The median duration of follow-up after surgery was 22 months (range, 1–37 months). With follow-up available in nine patients, seven relapsed, and only two remained disease free.ConclusionsThis series confirms the high rate of nodal spread in patients with bulky residual cervical disease after chemoradiotherapy. Furthermore, patients who underwent hysterectomy had a high complication rate. Only two patients are alive and disease free. The results of surgery are disappointing; surgery does not seem to improve the survival of these patients.


Obstetrics & Gynecology | 2004

Port-site implantation after laparoscopic treatment of borderline ovarian tumors.

Philippe Morice; Sophie Camatte; Dominique Larregain-Fournier; Anne Thoury; Pierre Duvillard; Damienne Castaigne

BACKGROUND: The aim of this article is to report 3 cases of port-site implantation after laparoscopic treatment of a borderline ovarian tumor. CASES: Three patients underwent a laparoscopic procedure for a serous (2 patients) or mucinous (1 patient) borderline ovarian tumor. In 2 patients, the port-site implantation was discovered during a later surgical procedure, and one was discovered clinically 11 months after the initial laparoscopic oophorectomy. Surgical resection of the port-site was the only treatment in all cases. These women are currently alive and disease-free 11, 23, and 51 months after the treatment of the scar metastasis. CONCLUSIONS: These results suggest that, unlike port-site metastasis in other gynecologic malignancies, the prognosis in patients with a port-site implantation after laparoscopic management of borderline ovarian tumor is excellent. The treatment of this complication is surgical resection.


Breast Care | 2012

Axillary Padding without Drainage after Axillary Lymphadenectomy – a Prospective Study of 299 Patients with Early Breast Cancer

Jean-Rémi Garbay; Anne Thoury; Etienne Moinon; Andrea Cavalcanti; Mario Di Palma; Guillaume Karsenti; Nicolas Leymarie; Benjamin Sarfati; F. Rimareix; Chafika Mazouni

Background: After lymphadenectomy for early breast cancer, seroma formation is a constant event requiring a suction drainage. This drainage is the strongest obstacle to reducing the hospital stay. Axillary padding without drainage appears to be a valuable option amid the various solutions for reducing the hospital stay. Methods: We conducted a comparison between 114 patients with padding and 185 patients with drainage. Data were obtained from 2 successive prospective studies. Results: The mean hospital stay was 2.4 days (range 1–4) in the padding group and 4.2 days (range 2–9) in the drainage group (p < 0.05). There were fewer needle aspirations for seroma in the padding group (8.8 vs. 23%, p < 0.05). At 6 weeks, only 28% (32/114) of the patients in the padding group reported pain versus 51% (94/185) in the drainage group. The mean pain intensity at 6 weeks was 3 and 4.3 respectively (p < 0.0001). Conclusion: Axillary padding without drainage was associated with a better post-operative course than suction drainage in this historical comparison, and the hospital stay was significantly shortened. There are only few series published on this new technique but they all indicate good feasibility and good tolerance. A large randomised multicentric evaluation is now warranted.


Case Reports | 2013

Malignant transformation of superficial peritoneal endometriosis lesion

Eva Marchand; Delphine Hequet; Anne Thoury; Emmanuel Barranger

A 63-year-old woman with no medical history underwent an abdominal surgery with hysterectomy and bilateral salpingo-oophorectomy for a 10 cm peritoneal cyst with increased cancer antigene-125. A large suspicious tumour of the Douglas space, with contact to the uterus and the rectal wall was described. The rest of the exploration was normal, specially the rest of the peritoneum. Histopathology revealed a malignant transformation of a superficial peritoneal endometriosis. Secondary surgery was thus completed by laparoscopy with bilateral pelvic and para-aortic lymph node dissections, omentectomy and multiple peritoneal biopsies. All staging samples were free of cancer; therefore no complementary therapy was administered. After 18 months of follow-up, consisting of clinical examination and pelvis magnetic resonance imaging every 6 months, we did not observe any recurrence. Malignant transformation of superficial peritoneal endometriosis is a rare disease and surgical management seems to be the main treatment.


Gynecologie Obstetrique & Fertilite | 2015

Comment je fais… une cœlioscopie rétropéritonéale avec insufflateur à pression constante

E. Marchand; Y. Delpech; Anne Thoury; I. Letendre; J. Sroussi; J.L. Bénifla

La lymphadénectomie lombo-aortique réalisée par cœlioscopie, notamment pour la stadification ganglionnaire dans les cancers du col localement avancés, ne doit pas retarder le traitement par radio-chimiothérapie concomitante. Initialement effectuée par cœlioscopie transpéritonéale, la lymphadénectomie lombo-aortique est réalisée depuis plus de dix ans par voie rétropéritonéale par des équipes entraı̂nées. La voie rétropéritonéale serait responsable de moins d’adhérences qui sont pourvoyeuses de complications lors de la radiothérapie [1]. Depuis 2011, l’utilisation d’une incision unique avec mono-trocart (single-port) a permis d’optimiser davantage cette technique. Celle-ci a été évaluée comme étant reproductible avec notamment un gain esthétique en terme de nombre d’incisions [2–4]. Récemment, le nouveau système d’insufflation Airseal mis au point dispose d’un design de flux circulatoires filtrés qui permet


European Journal of Cancer | 2004

Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases

Sophie Camatte; Philippe Morice; Anne Thoury; Virgine Fourchotte; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne


Annals of Oncology | 2004

Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery–radiation therapy

Philippe Morice; C. Deyrolle; Annie Rey; D. Atallah; Patricia Pautier; Sophie Camatte; Anne Thoury; Catherine Lhommé; Christine Haie-Meder; Damienne Castaigne


Fertility and Sterility | 2007

Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study

Anne Fortin; Philippe Morice; Anne Thoury; Sophie Camatte; Caroline Dhainaut; Patrick Madelenat


Annals of Oncology | 2004

Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients

Sophie Camatte; Philippe Morice; D. Atallah; Anne Thoury; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne


Ejso | 2004

Prognosis of stage III or IV primary peritoneal serous papillary carcinoma

Gil Dubernard; Philippe Morice; Annie Rey; Sophie Camatte; Virginie Fourchotte; Anne Thoury; Christophe Pomel; Patricia Pautier; Catherine Lhommé; Pierre Duvillard; Damienne Castaigne

Collaboration


Dive into the Anne Thoury's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annie Rey

Institut Gustave Roussy

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Atallah

Institut Gustave Roussy

View shared research outputs
Researchain Logo
Decentralizing Knowledge